钆塞酸增强MRI辅助征象对鉴别硬化型肝细胞癌与肝内胆管癌的附加价值
本回顾性研究纳入96例硬化型肝细胞癌与120例肝内胆管癌患者,评估钆塞酸增强MRI辅助征象在增强模式诊断基础上的附加价值。结果显示,将包膜、分隔和T2中央低信号加入增强模式诊断后,两名观察者诊断硬化型肝细胞癌的准确度、敏感度和特异度均显著提高。
要点
- 包膜、分隔和T2中央低信号是鉴别硬化型肝细胞癌与肝内胆管癌的独立辅助征象。
- 仅31.3%的硬化型肝细胞癌表现为典型肝细胞癌增强模式。
- 在增强模式基础上加入辅助征象可提高诊断硬化型肝细胞癌的准确度、敏感度和特异度。
核心结论
- 在钆塞酸增强MRI上,将包膜、分隔和T2中央低信号辅助征象加入常规增强模式诊断,可提高鉴别硬化型肝细胞癌与肝内胆管癌的准确度、敏感度和特异度。
研究设计与样本
- 回顾性研究,纳入96例硬化型肝细胞癌和120例肝内胆管癌患者,术前均行钆塞酸增强MRI,由两名观察者阅片。
关键影像表现/征象
- T2中央低信号、包膜和分隔是鉴别硬化型肝细胞癌与肝内胆管癌的显著且独立特征(p ≤ .06)。
- 典型肝细胞癌增强模式见于31.3%的硬化型肝细胞癌。
诊断标准与关键数值
- 观察者1:加入辅助征象后诊断硬化型肝细胞癌的准确度从78.9%升至93.8%,敏感度从74.5%升至96.4%,特异度从82.5%升至91.7%(p < .001、p < .001、p = .006)。
- 观察者2:加入辅助征象后诊断硬化型肝细胞癌的准确度从80.3%升至92.8%,敏感度从77.1%升至93.2%,特异度从82.9%升至92.5%(p < .001、p = .001、p = .005)。
临床应用与阅片要点
- 阅片时在增强模式基础上注意评估包膜、分隔和T2中央低信号,以辅助鉴别硬化型肝细胞癌与肝内胆管癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine ancillary features that help distinguish between scirrhous hepatocellular carcinoma (S-HCC) and intrahepatic cholangiocarcinoma (ICC) and investigate added value of ancillary features to enhancement pattern-based diagnosis on gadoxetic acid-enhanced MRI.
METHODS: This retrospective study included 96 patients with S-HCCs and 120 patients with ICCs who underwent gadoxetic acid MRI before surgical resection. Two observers reviewed MRIs of the tumours. After determining ancillary features for differentiating tumour types, we measured the diagnostic performance of adding ancillary features to enhancement pattern-based diagnosis.
RESULTS: T2 central darkness, capsule and septum were significant and independent features differentiating S-HCC from ICC (p ≤ .06). Adding ancillary features to enhancement pattern led to increased accuracy (observer 1, 78.9 vs. 93.8 %; observer 2, 80.3 vs. 92.8 %; p < .001), sensitivity (observer 1, 74.5 vs. 96.4 %; observer 2, 77.1 vs. 93.2 %; p < .001 and .001), and specificity (observer 1, 82.5 vs. 91.7 %; observer 2, 82.9 vs. 92.5 %; p = .006 and .005) for diagnosis of S-HCC by differentiation from ICC.
CONCLUSIONS: Adding ancillary features capsule, septum and T2 central darkness to conventional enhancement patterns on gadoxetic acid-enhanced MRI improved accuracy, sensitivity and specificity for S-HCC diagnosis with differentiation from ICC.
KEY POINTS: • Capsule, septum, and T2 central darkness were ancillary features for S-HCC. • A typical HCC enhancement was seen in 31.3% of S-HCCs. • Ancillary MRI features were useful in differentiation between S-HCC and ICC.
引用
- Choi SY, Kim YK, Min JH, et al. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. Eur Radiol. 2018. PMID: 29335868. doi:10.1007/s00330-017-5196-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。